We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Range of Tools Licensed to UK Institute of Cancer Research

By LabMedica International staff writers
Posted on 11 Feb 2010
UK scientists are working closely together to identify and develop new tools to help advance scientific efforts, particularly those applicable to research into the causes, prevention, diagnosis, and methods of treatment of cancer.

Dotmatics (Bishops Stortford, UK) has licensed its enterprise query, reporting, registration, and data management tools to The Institute of Cancer Research (ICR; London, UK). More...
The solution will primarily be used in the Cancer Research UK Center for Cancer Therapeutics to query, browse, analyze, and share chemical, biologic, and drug metabolism information across research programs and project teams.

Stephen Gallagher, chief executive officer of Dotmatics, said, "We began working with the ICR last year when it chose Dotmatics above other providers for research tools in the Cancer Research UK Center for Cancer Therapeutics. We are immensely proud to be working with such a prestigious organization and look forward to a close and fruitful relationship with the ICR and its partners.”

Prof. Julian Blagg, head of medicinal chemistry at the Center for Cancer Therapeutics said, "Dotmatics was chosen as our preferred partner to meet our chemoinformatics needs; the cost effectiveness and flexibility of the Dotmatics solution are particularly important to us. The Dotmatics team have been very helpful in the implementation of the platform across our center and we look forward to working with Dotmatics to develop and integrate new chemoinformatics tools to assist our cancer drug discovery work.”

By enabling discovery organizations to share and use their research information more efficiently, the goals are to facilitate the generation of strategic knowledge, making the right information available to the right person, and to boost customers' productivity by maximizing their information and knowledge awareness across the spectrum of their discovery activities.

Product features include (1) Browser, a web-based tool for querying, browsing, and visualizing biologic databases and any chemical database. (2) Vortex, a visualization and analytics platform for scientific and nonscientific data. (3) Gateway, a securely enables research teams to share information internally and with external partners. (4) Pinpoint, a powerful Oracle chemical cartridge for querying and integrating chemical databases. Pinpoint represents indexing and search performance at a cost-effective price. (5) Register, a flexible and scalable chemical registration system. (6) Nucleus, a map and import biologic and nonbiologic data files into an Oracle database. (7) Studies, a new standard in screening data management.

The ICR is Europe's leading cancer research center and works closely with partner the Royal Marsden NHS (National Health Service) Foundation Trust to ensure patients immediately benefit from new research. Together, the two organizations form the largest comprehensive cancer center in Europe.

Related Links:
Dotmatics
Institute of Cancer Research



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.